Irreversible Pepsin Fraction
IPF is a therapeutic platform technology that can be used to facilitate a broad range of applications.
It is free from neurological, gastrointestinal and hematological side effects.
IPF has not shown to be subject to viral resistance and is cost effective.
Immunotherapy has the potential to provide an alternative and/or complementary treatment for most types of cancer. The advantage of immunotherapy over radiation and chemotherapy is that it can act specifically against the tumor without causing normal tissue damage.
ITP Drug Product
IMMUNE-THERAPEUTIC PROTEIN is isolated from porsine pepsin which is irreversible, modified, and fractionate to the sequence IPF. It appears to present a novel mechanism to reduce viral burden and stimulate innate immune responses to the virus for patients with significant malignan influence .